ORALLY ACTIVE LEUKEMIA INHIBITORY FACTOR (LIF) ANTAGONISTS FOR THE TREATMENT OF CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240124515A1
SERIAL NO

18263695

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are novel LIF/LIFR inhibitors that exhibit improved cytotoxicity and bioavailability. These LIF/LIFR inhibitors are particularly useful for the treatment of tumors associated with overexpression of LIF.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EVESTRA INCSAN ANTONIO TEXAS 78245

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ahmed, Gulzar San Antonio, US 22 364
Konda, Swapna San Antonio, US 1 0
Nair, Hareesh B San Antonio, US 1 0
Thamma, Bindu San Antonio, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation